Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 1

Conditions

Sarcoma 2Cholangiocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Radiation Injuries 1Neoplasm Metastasis 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colorectal Liver Metastases 1Breast Neoplasms 1

Interventions

Doxorubicin 27pembrolizumab 24Radiotherapy 20Cyclophosphamide 18Magnetic Resonance Spectroscopy 17Specimen Handling 14Nivolumab 14Ifosfamide 13Gemcitabine 13Biopsy 11Surgical Procedures, Operative 10Radiation 10Temozolomide 9X-Rays 8Ipilimumab 8pazopanib 7fludarabine 7cabozantinib 7Irinotecan 7Blood Specimen Collection 7tazemetostat 6liposomal doxorubicin 6Trabectedin 6Surveys and Questionnaires 6Phantoms, Imaging 6olaparib 5eribulin 5atezolizumab 5Vincristine 5Standard of Care 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × Base Sequence × 1 year × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

Completed
24 enrolled
GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡